Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer

被引:3
作者
Czerwinski, Michal [1 ,2 ]
Bednarska-Czerwinska, Anna [2 ,3 ]
Zmarzly, Nikola [3 ]
Boron, Dariusz [3 ,4 ,5 ]
Oplawski, Marcin [4 ]
Grabarek, Beniamin Oskar [3 ,4 ,5 ]
机构
[1] Amer Med Clin, PL-40600 Katowice, Poland
[2] Gynctr Fertil Clin, PL-40121 Katowice, Poland
[3] Univ Technol Katowice, Fac Med, Dept Histol Cytophysiol & Embryol, PL-41800 Zabrze, Poland
[4] Ludwik Rydygier Mem Specialized Hosp, Dept Gynecol & Obstet Gynecol Oncol, PL-31826 Krakow, Poland
[5] TOMMED Specjalisci Zdrowia, Dept Gynecol & Obstet, Fredry 22, PL-40662 Katowice, Poland
关键词
endometrial cancer; biogenic amines; histamine receptors; dopamine receptors; expression profile; HISTAMINE-RECEPTOR ANTAGONISTS; H1; RECEPTOR; GROWTH-FACTOR; UP-REGULATION; DOPAMINE; CARCINOGENESIS; TRANSCRIPTION; BREAST; H3;
D O I
10.3390/jcm10214872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biogenic amines, such as adrenaline, noradrenaline, histamine, dopamine, and serotonin are important neurotransmitters that also regulate cell viability. Their detection and analysis are helpful in the diagnosis of many diseases, including cancer. The aim of this study was to determine the expression profile of the biogenic amine-related genes and proteins in endometrioid endometrial cancer compared to the control group. The material consisted of endometrial tissue samples and whole blood collected from 30 endometrioid endometrial cancer patients and 30 cancer-free patients. The gene expression was determined by the mRNA microarrays and validated by qRT-PCR. Protein levels were determined in the serum by the enzyme-linked immunosorbent assay (ELISA). Overexpression of histamine H1-H3 receptors and early growth response 1 and silencing of calmodulin, the histamine H4 receptor, and the dopamine D5 receptor have been reported in endometrioid endometrial cancer. The obtained results indicate disturbances in the signaling activated by histamine and dopamine receptors, which could potentially contribute to the progression of endometrioid endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes
    Agata Sirek
    Tomasz Sirek
    Robert Nowakowski
    Przemysław Borawski
    Piotr Ossowski
    Katarzyna Mitka-Krysiak
    Nikola Zmarzły
    Kacper Boroń
    Michał Chalcarz
    Bernadeta Kuraszewska
    Mariola Szulik
    Dariusz Boroń
    Beniamin Oskar Grabarek
    Breast Cancer Research and Treatment, 2025, 212 (2) : 387 - 406
  • [32] Expression of DNA repair proteins in endometrial cancer predicts disease outcome
    Mhawech-Fauceglia, Paulette
    Wang, Dan
    Kim, Grace
    Sharifian, Maryarn
    Chen, Xiwie
    Liu, Qian
    Lin, Yvonne G.
    Liu, Song
    Pejovic, Tanja
    GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 593 - 598
  • [33] Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor
    Mylonas, Ioannis
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 27 (03) : 309 - 318
  • [34] Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer
    Gottwald, L.
    Pasz-Walczak, G.
    Piekarski, J.
    Szwalski, J.
    Kubiak, R.
    Spych, M.
    Suzin, J.
    Tylinski, W.
    Sek, P.
    Jeziorski, A.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 34 (04) : 346 - 349
  • [35] Comparative Evaluation of Estrogen and Progesterone Receptor Expression With Connexins 26 and 43 in Endometrial Cancer
    Lesniewicz, Tomasz
    Kanczuga-Koda, Luiza
    Baltaziak, Marek
    Jarzabek, Katarzyna
    Rutkowski, Ryszard
    Koda, Mariusz
    Wincewicz, Andrzej
    Sulkowska, Mariola
    Sulkowski, Stanislaw
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) : 1253 - 1257
  • [36] Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser167 in endometrioid endometrial cancer
    Kato, Eiichi
    Orisaka, Makoto
    Kurokawa, Tetsuji
    Chino, Yoko
    Fujita, Yuko
    Shinagawa, Akiko
    Yoshida, Yoshio
    CANCER SCIENCE, 2014, 105 (10) : 1307 - 1312
  • [37] Current practice patterns in nodal evaluation and adjuvant treatment of advanced stage endometrioid endometrial cancer: An SGO survey
    Parker, Jessica E.
    Miller, David S.
    Lee, Jessica
    Carlson, Matthew
    Lococo, Salvatore
    Lea, Jayanthi S.
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 34
  • [38] Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention
    Huang, Ting
    Zhou, Jingyi
    Wang, Jianliu
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (03): : 1065 - 1078
  • [39] Obesity and altered angiogenic-related gene expression in endometrial cancer
    Cobb, Lauren Patterson
    Siamakpour-Reihani, Sharareh
    Zhang, Dadong
    Qin, Xiaodi
    Owzar, Kouros
    Zhou, Chunxiao
    Conrads, Thomas P.
    Maxwell, G. Larry
    Darcy, Kathleen M.
    Bateman, Nicholas W.
    Litzi, Tracy
    Bae-Jump, Victoria
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 163 (02) : 320 - 326
  • [40] Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer
    Alnafakh, Rafah
    Saretzki, Gabriele
    Midgley, Angela
    Flynn, James
    Kamal, Areege M.
    Dobson, Lucy
    Natarajan, Purushothaman
    Stringfellow, Helen
    Martin-Hirsch, Pierre
    DeCruze, Shandya B.
    Coupland, Sarah E.
    Hapangama, Dharani K.
    CANCERS, 2021, 13 (02) : 1 - 19